Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biobest financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Revenue
€66.5 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 71.8M | 72.2M | 66.5M |
| Cost of goods sold | 60.4M | 63.2M | 68.8M |
| Gross profit | 11.4M | 9.0M | (2.2M) |
| Gross profit margin, % | 15.9% | 12.5% | -3.4% |
| General and administrative expense | 15.2M | 16.5M | 19.2M |
| Operating expense total | 17.4M | 18.3M | 23.4M |
| Depreciation and amortization | 1.5M | 1.7M | 3.4M |
| EBIT | (1.9M) | (2.9M) | (8.6M) |
| EBIT margin, % | -2.7% | -4.0% | -12.9% |
| Interest expense | 2.5M | 4.3M | 4.6M |
| Pre tax profit | 3.5M | (2.0M) | (9.4M) |
| Income tax expense | 33.3K | 55.2K | 12.4K |
| Net Income | 3.4M | (2.1M) | (9.4M) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |